160 related articles for article (PubMed ID: 10029517)
1. Structural elements and limited proteolysis of CD39 influence ATP diphosphohydrolase activity.
Schulte am Esch J; Sévigny J; Kaczmarek E; Siegel JB; Imai M; Koziak K; Beaudoin AR; Robson SC
Biochemistry; 1999 Feb; 38(8):2248-58. PubMed ID: 10029517
[TBL] [Abstract][Full Text] [Related]
2. Analysis of CD39/ATP diphosphohydrolase (ATPDase) expression in endothelial cells, platelets and leukocytes.
Koziak K; Sévigny J; Robson SC; Siegel JB; Kaczmarek E
Thromb Haemost; 1999 Nov; 82(5):1538-44. PubMed ID: 10595651
[TBL] [Abstract][Full Text] [Related]
3. CD39 as a caveolar-associated ectonucleotidase.
Kittel A; Kaczmarek E; Sevigny J; Lengyel K; Csizmadia E; Robson SC
Biochem Biophys Res Commun; 1999 Sep; 262(3):596-9. PubMed ID: 10471369
[TBL] [Abstract][Full Text] [Related]
4. Constraints imposed by transmembrane domains affect enzymatic activity of membrane-associated human CD39/NTPDase1 mutants.
Musi E; Islam N; Drosopoulos JH
Arch Biochem Biophys; 2007 May; 461(1):30-9. PubMed ID: 17374358
[TBL] [Abstract][Full Text] [Related]
5. Dynamic motions of CD39 transmembrane domains regulate and are regulated by the enzymatic active site.
Grinthal A; Guidotti G
Biochemistry; 2004 Nov; 43(43):13849-58. PubMed ID: 15504047
[TBL] [Abstract][Full Text] [Related]
6. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation.
Robson SC; Wu Y; Sun X; Knosalla C; Dwyer K; Enjyoji K
Semin Thromb Hemost; 2005 Apr; 31(2):217-33. PubMed ID: 15852225
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
[TBL] [Abstract][Full Text] [Related]
8. The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization.
Maliszewski CR; Delespesse GJ; Schoenborn MA; Armitage RJ; Fanslow WC; Nakajima T; Baker E; Sutherland GR; Poindexter K; Birks C
J Immunol; 1994 Oct; 153(8):3574-83. PubMed ID: 7930580
[TBL] [Abstract][Full Text] [Related]
9. Substitution of His59 converts CD39 apyrase into an ADPase in a quaternary structure dependent manner.
Grinthal A; Guidotti G
Biochemistry; 2000 Jan; 39(1):9-16. PubMed ID: 10625474
[TBL] [Abstract][Full Text] [Related]
10. Identification and immunolocalization of two isoforms of ATP-diphosphohydrolase (ATPDase) in the pig immune system.
Benrezzak O; Grondin G; Sévigny J; Gendron FP; Rousseau E; D'Orléans-Juste P; Beaudoin AR
Arch Biochem Biophys; 1999 Oct; 370(2):314-22. PubMed ID: 10510290
[TBL] [Abstract][Full Text] [Related]
11. Reversal of thrombin-induced deactivation of CD39/ATPDase in endothelial cells by HMG-CoA reductase inhibition: effects on Rho-GTPase and adenosine nucleotide metabolism.
Kaneider NC; Egger P; Dunzendorfer S; Noris P; Balduini CL; Gritti D; Ricevuti G; Wiedermann CJ
Arterioscler Thromb Vasc Biol; 2002 Jun; 22(6):894-900. PubMed ID: 12067895
[TBL] [Abstract][Full Text] [Related]
12. Transmembrane domains confer different substrate specificities and adenosine diphosphate hydrolysis mechanisms on CD39, CD39L1, and chimeras.
Grinthal A; Guidotti G
Biochemistry; 2002 Feb; 41(6):1947-56. PubMed ID: 11827541
[TBL] [Abstract][Full Text] [Related]
13. Soluble apyrases release adp during ATP hydrolysis.
Chen W; Guidotti G
Biochem Biophys Res Commun; 2001 Mar; 282(1):90-5. PubMed ID: 11263976
[TBL] [Abstract][Full Text] [Related]
14. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases.
Marcus AJ; Broekman MJ; Drosopoulos JH; Islam N; Pinsky DJ; Sesti C; Levi R
J Pharmacol Exp Ther; 2003 Apr; 305(1):9-16. PubMed ID: 12649347
[TBL] [Abstract][Full Text] [Related]
15. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation.
Enjyoji K; Sévigny J; Lin Y; Frenette PS; Christie PD; Esch JS; Imai M; Edelberg JM; Rayburn H; Lech M; Beeler DL; Csizmadia E; Wagner DD; Robson SC; Rosenberg RD
Nat Med; 1999 Sep; 5(9):1010-7. PubMed ID: 10470077
[TBL] [Abstract][Full Text] [Related]
16. Ectonucleoside triphosphate diphosphohydrolase 1/CD39, localized in neurons of human and porcine heart, modulates ATP-induced norepinephrine exocytosis.
Machida T; Heerdt PM; Reid AC; Schäfer U; Silver RB; Broekman MJ; Marcus AJ; Levi R
J Pharmacol Exp Ther; 2005 May; 313(2):570-7. PubMed ID: 15647328
[TBL] [Abstract][Full Text] [Related]
17. Palmitoylation targets CD39/endothelial ATP diphosphohydrolase to caveolae.
Koziak K; Kaczmarek E; Kittel A; Sévigny J; Blusztajn JK; Schulte Am Esch J; Imai M; Guckelberger O; Goepfert C; Qawi I; Robson SC
J Biol Chem; 2000 Jan; 275(3):2057-62. PubMed ID: 10636909
[TBL] [Abstract][Full Text] [Related]
18. CD39 modulates IL-1 release from activated endothelial cells.
Imai M; Goepfert C; Kaczmarek E; Robson SC
Biochem Biophys Res Commun; 2000 Apr; 270(1):272-8. PubMed ID: 10733939
[TBL] [Abstract][Full Text] [Related]
19. CD39 reveals novel insights into the role of transmembrane domains in protein processing, apical targeting and activity.
Papanikolaou A; Papafotika A; Christoforidis S
Traffic; 2011 Sep; 12(9):1148-65. PubMed ID: 21711430
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of CD39/vascular ATP diphosphohydrolase.
Kaczmarek E; Koziak K; Sévigny J; Siegel JB; Anrather J; Beaudoin AR; Bach FH; Robson SC
J Biol Chem; 1996 Dec; 271(51):33116-22. PubMed ID: 8955160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
